Effect of endothelin-1 on intracellular glutathione and lipid peroxide availability and on the secretion of vasoactive substances by human umbilical vein endothelial cells

European Journal of Clinical Investigation

Volumn 32, Issue 8, 2002, Pages 556-562

  Scalera, Fortunato ^a   Dittrich, R ^a   Beckmann, M W ^a   Beinder, E ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Endothelin 1; Glutathione; Human umbilical vein endothelial cells; Lipid peroxides; Preeclampsia; Vasoactive substances

Indexed keywords

ENDOTHELIN 1; GLUTATHIONE; LIPID PEROXIDE; NITRIC OXIDE; PROSTACYCLIN; THROMBOXANE A2; VASOACTIVE AGENT;

AMINO ACID ANALYSIS; ARTICLE; CELL ASSAY; CELL LYSATE; CELL PROLIFERATION; CELL SECRETION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INCUBATION TIME; OXIDATIVE STRESS; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; UMBILICAL VEIN;

CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; FEMALE; GLUTATHIONE; HUMANS; INTRACELLULAR FLUID; LIPID PEROXIDES; NITRIC OXIDE; PRE-ECLAMPSIA; PREGNANCY; THROMBOXANE A2; UMBILICAL VEINS;

EID: 0037003397     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2002.01040.x     Document Type: Article

References (38)

1. Yanagisawa M, Kurihara H, Kimura Y, Tomobe Y, Kobayashi M et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
2. Haynes WG, Webb DJ. Endothelin as a regulator of cardiovascular function in health and disease. J Hypertension 1998;16:1081-98.
3. Rubanyi GM, Polokoff MA. Endothelins. molecular biology, biochemistry, pharmacology physiology and pathophysiology. Pharmacol Rev 1994;46 (3):325-415.
4. Taylor RN, Varma M, Teng NN, Robertts JM. Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J Clin Endocrinol Metab 1990;71 (6):1675-7.
5. Iahara Y, Sagawa N, Hasegawa M, Okagaki A, Li XM et al. Concentrations of endothelin-1 in maternal and umbilical cord blood at various stages of pregnancy. J Cardiovasc Pharmacol 1991;17 (7):S443-5.
6. Nova A, Sibai BM, Barton JR, Mercer BM, Mitchell MD. Maternal plasma level of endothelin is increased in preeclampsia. Am J Obstet Gynecol 1991;165 (3):724-7.
7. Samuels P, Steinfeld JD, Braitman LE, Rhoa MF, Cines DB, McCrae KR. Plasma concentration of endothelin-1 in women with cocaine-associated pregnancy complications. Am J Obstet Gynecol 1993;168 (2):528-33.
8. Kraayenbrink AA, Dekker GA, van Kamp GJ, van Geijn HP. Endothelial vasoactive mediators in preeclampsia. Am J Obstet Gynecol 1993;169:160-5.
9. Rust OA, Bofill JA, Zappe DH, Hall JE, Burnett JC, Martin JN. The origin of endothelin-1 in patients with severe preeclampsia. Obstet Gynecol 1997;89:754-7.
10. Ferreira-d, e-Almeida JA, Amenta F, Cardoso F, Polnia JJ. Association of circulating endothelin and noradrenaline with increased calcium-channel binding sites in the placental bed in pre-eclampsia. Br J Obstet Gynaecol 1998;105:1104-12.
11. Weir FJ, Ohlsson A, Fong K, Amankwah K, Coceani F. Does endothelin-1 reduce superior mesenteric artery blood flow velocity in preterm neonates? Arch Dis Child Fetal Neonatal Ed 1999;80:F123-7.
12. Battistini B, D'Orl,ans-Juste P, Sirois P. Endothelins: circulating plasma levels and presence in other biologic fluids. Lab Invest 1993;68 (6):600-28.
13. Greenberg SG, Baker SC, Yang D, Clark KE. Effects of continuous infusion of endothelin-1 in pregnant sheep. Hypertens 1997;30:1585-90.
14. Saijonmaa O, Nyman T, Fyhrquist F. Endothelin-1 stimulates ist own synthesis in human endothelial cells. Biochem Biophys Res Commun 1992;188 (1):286-91.
15. Benatti L, Fabbrini MS, Patrono C. Regulation of endothelin-1 biosynthesis. Ann N Y Acad Sci 1994;714:109-21.
16. Scalera F, Schlembach D, Beinder E. Production of vasoactive substances by human umbilical vein endothelial cells after incubation with serum from preeclamptic patients. Eur J Obstet Gynecol Reprod Biol 2001;99 (2):172-8.
17. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989;161:1200-4.
18. Friedman SA, Taylor RN, Roberts JM. Pathophysiology of preeclampsia. Clin Perinatol 1991;18:661-82.
19. Hubel CA, Roberts JM, Taylor RN, Musci TJ, Rodgers GM, McLaughlin MK. Lipid peroxidation in pregnancy. New perspectives on preeclampsia. Am J Obstet Gynecol 1989;161:1025-34.
20. Deneke SM, Fanburg BL. Regulation of cellular glutathione. Am J Physiol 1989;257:L163-73.
21. Davidge ST. Oxidative stress and altered endothelial cell function in preeclampsia. Semin Reprod Endocrinol 1998;16 (1):65-73.
22. Hubel CA. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 1999;222 (3):222-35.
23. Morgan SJ, Darling DC. Zellzahlbestimmung. In: Morgan SJ, Darling DC, editors. Kultur tierischer Zellen. Heidelberg: Spectrum Akademischer Verlag GmbH; 1994. pp. 69-73.
24. Chappell LC, Seed PT, Briley AL, Kelly FJ, Lee R et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a radomised trial. Lancet 1994;354:810-6.
25. Chambers JC, Fusi L, Malik IS, Haskard DO, De Swiet M, Kooner JS. Association of maternal endothelial dysfunction with preeclampsia. JAMA 2001;285 (12):1607-12.
26. Regan CL, Levine RJ, Baird DD, Ewell MG, Martz KL et al. No evidence for lipid peroxidation in severe preeclampsia. Am J Obstet Gynecol 2001;185:572-8.
27. Fitzgerald DJ, Entman SS, Mulloy K, Fitzgerald GA. Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension. Circulation 1987;75 (5):956-63.
28. Satoh K, Seki H, Sakamoto H. Role of prostaglandins in pregnancy-induced hypertension. Am J Kidney Dis 1991;17 (2):133-8.
29. Wang Y, Walsh SW, Kay HH. Placental lipid peroxides and thromboxane are increased and prostacyclin is decreased in women with preeclampsia. Am J Obstet Gynecol 1992;167 (4):946-9.
30. Duerrschmidt N, Wippich N, Goettsch W, Broemme HJ, Morawietz H. Endothelin-1 induces NAD (P) H oxidase in human endothelial cells. Bioch Biophy Res Commun 2000;269:713-7.
31. Little RU, Gladen BC. Levels of lipid peroxides in uncomplicated pregnancy: a review of the literature. Reprod Toxicol 1999;13:347-52.
32. McCay PB, Powell SR. Relationship between glutathione and chemically induced lipid peroxidation. In: Dolphin D, Poulson R, Avramovic O, editors. B Glutathione: Chemical, Biochemical and Medical Aspects. New York: J Wiley and Son. 1989.pp.111-52.
33. Bannai S, Tateishi N. Role of membrane transport in metabolism and function of glutathione in mammals. J Membr Biol 1986;89 (1):1-8.
34. Gray CA. Signal transduction mechanism of the endothelins. In: Gray GA, Webb DJ, editors. Molecular Biology and Pharmacology of the Endothelins. Heidelberg: Springer-Verlag;1995.pp. 95-114.
35. Warso MA, Lands WEM. Lipid peroxidation in relation to prostacyclin and thromboxane physiology and pathophysiology. Br Med Bull 1983;39:277-80.
36. Wang J, Zhen E, Guo Z, Lu Y. Effect of hyperlipidemic serum on lipid peroxidation, synthesis of prostacyclin and thromboxane by cultured endothelial cells. protective effect of antioxidants. Free Radic Biol Med 1989;7:243-9.
37. Beckmann JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol 1996;271:C1424-37.
38. Beinder E, Scalera F, Schlembach D. Influence of reduced intracellular glutathione availability on the secretion of vasoactive substances by human umbilical vein endothelial cells. Hypertens Pregnancy 2001;20 (1):45-56.